scispace - formally typeset
L

Lee M. Ellis

Researcher at University of Texas MD Anderson Cancer Center

Publications -  364
Citations -  33895

Lee M. Ellis is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 105, co-authored 355 publications receiving 31804 citations.

Papers
More filters
Journal ArticleDOI

Drug development: Raise standards for preclinical cancer research

C. Glenn Begley, +1 more
- 28 Mar 2012 - 
TL;DR: C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.
Journal ArticleDOI

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

TL;DR: Efficacy and tolerability of FOLFIRI + B appeared favorable to historical controls in this single arm study, and there was a shift in balance of CAFs, with a rise in alternate pro-angiogenic cytokines and myeloid recruitment factors in subsets of patients that may represent mechanisms of resistance.
Journal ArticleDOI

Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1

TL;DR: It is shown that, without direct cell-cell contact, ECs secrete factors that promoted the CSC phenotype in CRC cells via Notch activation, and ECs play an active role in promoting Notch signaling and the C SC phenotype by secreting soluble Jagged-1.
Journal ArticleDOI

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

TL;DR: The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology.